Acceleron Pharma
XLRN
$178.75
Share price
0.00%
Change (1 day)
15,048.31%
Change (1 year)
Categories
Market capitalization of Acceleron Pharma (XLRN)
Market cap: $10.93 Billion
As of May 2024 Acceleron Pharma has a market cap of $10.93 Billion. This makes Acceleron Pharma the world's 1555th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Acceleron Pharma from 2013 to 2022
End of year Market Cap
| Year | Market cap | Change |
|---|---|---|
| 2022 | $10.93 B | 0% |
| 2021 | $10.93 B | 41.81% |
| 2020 | $7.70 B | 173.68% |
| 2019 | $2.81 B | 39.81% |
| 2018 | $2.01 B | 4.94% |
| 2017 | $1.91 B | 99.29% |
| 2016 | $0.96 B | -40.7% |
| 2015 | $1.62 B | 28.56% |
| 2014 | $1.26 B | 12.56% |
| 2013 | $1.12 B |
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $364.32 B | 3,232.75% | 🇺🇸 USA |
 Pfizer PFE | $161.15 B | 1,374.24% | 🇺🇸 USA |
 Amgen AMGN | $167.05 B | 1,428.15% | 🇺🇸 USA |
 Regeneron Pharmaceuticals REGN | $107.64 B | 884.73% | 🇺🇸 USA |
 Sangamo Therapeutics
SGMO | $0.11 B | -98.92% | 🇺🇸 USA |
 Onconova Therapeutics ONTX | $20.9 M | -99.81% | 🇺🇸 USA |
 bluebird bio
BLUE | $0.20 B | -98.11% | 🇺🇸 USA |